ENTRY       D11229                      Drug
NAME        Brontictuzumab (USAN/INN)
FORMULA     C6392H9862O1980N1710S50
EXACT_MASS  143856.9615
MOL_WEIGHT  143946.2177
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKI SCKVSGYTLR GYWIEWVRQA PGKGLEWIGQ ILPGTGRTNY
            NEKFKGRVTM TADTSTDTAY MELSSLRSED TAVYYCARFD GNYGYYAMDY WGQGTTVTVS
            SASTKGPSVF PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSNFGTQ TYTCNVDHKP SNTKVDKTVE RKCCVECPPC PAPPVAGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVQFNWYVD GVEVHNAKTK PREEQFNSTF
            RVVSVLTVVH QDWLNGKEYK CKVSNKGLPA PIEKTISKTK GQPREPQVYT LPPSREEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPMLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            QAVVTQEPSL TVSPGGTVTL TCRSSTGAVT TSNYANWFQQ KPGQAPRTLI GGTNNRAPGV
            PARFSGSLLG GKAALTLSGA QPEDEAEYYC ALWYSNHWVF GGGTKLTVLG QPKAAPSVTL
            FPPSSEELQA NKATLVCLVS DFYPGAVTVA WKADGSPVKV GVETTKPSKQ SNNKYAASSY
            LSLTPEQWKS HRSYSCRVTH EGSTVEKTVA PAECS
            (Disulfide bridge: H22-H96, H135-L214, H148-H204, H223-H'223, H224-H'224, H227-H'227, H230-H'230, H261-H321, H367-H425, H'22-H'96, H'135-L'214, H'148-H'204, H'261-H'321, H'367-H'425, L22-L90, L137-L196, L'22-L'90, L'137-L'196)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
TARGET      NOTCH1 [HSA:4851] [KO:K02599]
  PATHWAY   hsa04330(4851)  Notch signaling pathway
            hsa05200(4851)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Signaling molecules
               Notch signaling
                NOTCH1
                 D11229  Brontictuzumab (USAN/INN)
DBLINKS     CAS: 1447814-75-6
            PubChem: 384585207
///
